We are pleased to have been able to attend the CIPA Biotech Conference, held this year from 26 to 27 November 2009 at South Lodge Hotel, Horsham, West Sussex.

The programme is as follows:

Law Updates

  • UK Law Update - Lawrence Cullen (IPO) and Philip Webbet
  • Latest developments in EP Law and Practice - Siobhan Yates, George Schlich
  • US Law Update - Jane Licata
  • Australian and NZ Law Update - Amanda Stark and Greg Lynch


  • Plant varieties
  • Traditional knowledge
  • Life cycle management
  • Data exclusivity and biosimilars
  • Generics
  • Litigating pharma/bio patents
  • European Commission Report on the Pharmaceutical Industry

Science presentation: siRNA today, the development of nucleic acid therapy in the 21st century


  • The Llama in the Room (Tim Roberts)
  • Hot Topics in Plant Variety Rights (Thomas Bouvet, Véron & Associés)
  • Generics – How Does the Market Work? (Andrew Brown, Teva U.K.)
  • The Death of Lifecycle Management (Sarah Boxall, Boxall IPM Ltd. & M)arion Rees, Oxford Nanopore Technologies Ltd.
  • Data Exclusivity Protection for Chemical & Biological Drugs in the Major World Healthcare Markets (Diana Wilcock, Xoma (US) LLC)
  • Stewards’ Inquiry? The European Commission’s Report on Generic Entry in the Pharma Sector (Duncan Curley, Innovate Legal)
  • Litigating Patents in the UK without being Vexatious or Abusive (Rob Burrows & Liz Cohen, Bristows)
  • RNAi Science (Mark Edbrook)e, GlaxoSmithKline
  • Biotech Litigation – Protein for the Judiciary (Mr. Justice Floyd, Patents Court)
← Back to News